Clinical trial
A Prospective Observational Study Investigating the Impact of Migalastat on Cardiovascular Structure and Function in Fabry Disease
NCT03949920 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study Investigating the Impact of Migalastat on Cardiovascular Structure and Function in Fabry Disease
- Lead sponsor
- Manchester University NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 16, 2019
- Completion date
- December 31, 2023
- Enrollment
- 21 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.